Rheumatoid arthritis trials in China

In China 53 Also abroad 351

53 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in China
MYTP01 for Immune-Mediated Diseases
Where
Hangzhou
Age
18 years to 65 years
People
160
Run by
Zhejiang Provincial People's Hospital
See details and how to joinNCT07901764
No phaseTaking people
GenAI-Assisted Rheumatoid Arthritis Bone Erosion Risk Assessment and DMARD Selection
Where
Beijing
Age
18 years and over
People
100
Run by
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
See details and how to joinNCT07914907
Phase 1Taking people
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
Where
Beijing, Luoyang, Shanghai, Wuhan
Age
18 years to 75 years
People
21 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07363590 · EU 2025-523412-36-00
Phase 1Taking people
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Where
Beijing, Chengdu, Nanjing
Age
18 years to 65 years
People
48 worldwide
Run by
AstraZeneca
See details and how to joinNCT07201558 · EU 2025-522273-10-00
Phase 1/2Taking people
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Where
Beijing, Guangzhou, Nanchang, Shanghai, Zhengzhou
Age
18 years to 65 years
People
84 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07412704 · EU 2025-520666-22-00
Phase 1Taking people
A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
Where
Beijing
Age
18 years to 65 years
People
12
Run by
China Immunotech (Beijing) Biotechnology Co., Ltd.
See details and how to joinNCT06978647
Phase 1Taking people
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Where
Beijing, Shanghai, Wuhan, Zhengzhou
Age
18 years to 70 years
People
72 worldwide
Run by
AstraZeneca
See details and how to joinNCT06916806 · EU 2024-519015-34-00
Phase 2Taking people
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Where
Beijing, Changchun, Changsha, Guangzhou, Jiujiang, Kunming, Linyi, Nanchong, Panjin, Pingxiang, Shantou, Xuzhou, Yangzhou, Zhengzhou
Age
18 years and over
People
320 worldwide
Run by
AstraZeneca
See details and how to joinNCT07276581
Phase 1Taking people
A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
Where
Beijing, Changsha, Hefei, Shanghai, Wenzhou, Wuhan
Age
18 years to 55 years
People
68 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07276958 · EU 2026-527207-25-00
Phase 2Taking people
Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis
Where
Beijing
Age
18 years to 70 years
People
24
Run by
Toll Biotech Co. Ltd. (Beijing)
See details and how to joinNCT07408024
Phase 2Taking people
A Phase IIa Study of JAB-8263 in Patients With Active Rheumatoid Arthritis
Where
Beijing
Age
18 years to 75 years
People
32
Run by
Jacobio Pharmaceuticals Co., Ltd.
See details and how to joinNCT07684157
Phase 2Enrolling by invitation
TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs
Where
Beijing
Age
18 years to 70 years
People
90
Run by
Hangzhou Highlightll Pharmaceutical Co., Ltd
See details and how to joinNCT07748728
Phase 2Taking people
Faecal Microbiota Transplantation in Patients With Refractory Rheumatoid Arthritis
Where
Beijing
Age
18 years to 65 years
People
40
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07639177
Phase 4Not yet taking people in China
Treatment Strategy for Patients With RA-ILD
Where
Beijing, Changchun, Chongqing, Dalian, Handan, Hangzhou, Hefei, Hohhot, Jiujiang, Lanzhou, Luoyang, Nanchang, Nanjing, Nanning, Taiyuan, Ürümqi, Xingyi, Yan’an, Yinchuan
Age
18 years to 80 years
People
204
Run by
Chinese SLE Treatment And Research Group
See details and how to joinNCT07643038
Phase 2Taking people
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
Where
Beijing, Changchun, Changsha, Chongqing, Dalian, Dongying, Guangzhou, Haikou, Harbin, Hefei, Hengyang, Huaihua, Jiangmen, Kaifeng, Kunming, Linfen, Linyi, Nanchang, Nanning, Nantong, Ningbo, Qingdao, Quanzhou, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Taiyuan, Ürümqi, Weifang, Wenzhou, Wuhan, Yangzhou, Yantai, Zhengzhou, Zibo
Age
18 years and over
People
420
Run by
Peking University People's Hospital
See details and how to joinNCT07796516
No phaseEnrolling by invitation
Mass Spectrometry-based Immune Profiling in Autoimmune Diseases
Where
Beijing
Age
18 years and over
People
500
Run by
Peking University People's Hospital
See details and how to joinNCT07188285
Phase 1Taking people
Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）
Where
Hefei
Age
18 years to 69 years
People
30
Run by
Shenzhen MagicRNA Biotechnology Co., Ltd
See details and how to joinNCT06801119
Phase 4Taking people
Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis
Where
Shanghai
Age
18 years to 70 years
People
300
Run by
Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
See details and how to joinNCT07721142
No phaseTaking people
Clinical Cohort Construction and Therapeutic Effect Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Rheumatoid Arthritis
Where
Shanghai
Age
18 years and over
People
10,000
Run by
Dongyi He
See details and how to joinNCT07484243
Phase 2Taking people
Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD
Where
Beijing
Age
18 years to 70 years
People
450
Run by
Changchun GeneScience Pharmaceutical Co., Ltd.
See details and how to joinNCT07423533
No phaseNot yet taking people in China
A Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases
Where
Beijing
Age
18 years to 75 years
People
75
Run by
Beijing GoBroad Hospital
See details and how to joinNCT07593911
No phaseTaking people
Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis
Where
Foshan, Guangzhou, Jieyang, Shantou
Age
18 years to 65 years
People
130
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06301373
No phaseTaking people
Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
Where
Nanjing
Age
18 years to 70 years
People
72
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07558850
No phaseTaking people
Fucoidan in the Treatment of Active Rheumatoid Arthritis
Where
Beijing
Age
18 years to 65 years
People
40
Run by
Peking University People's Hospital
See details and how to joinNCT07045896
No phaseTaking people
Prospective Cohort Study on Refractory Rheumatoid Arthritis
Where
Beijing
Age
18 years and over
People
200
Run by
Peking University Third Hospital
See details and how to joinNCT07126431